1
|
Wang B, Wu Z, Zhang R, Chen Y, Dong J, Qi X. Retrospective analysis of safety and efficacy of enhanced recovery pathways in stage II-III colorectal cancer patients submitted to surgery and adjuvant therapy. World J Surg Oncol 2021; 19:99. [PMID: 33823871 PMCID: PMC8025484 DOI: 10.1186/s12957-021-02203-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2021] [Accepted: 03/18/2021] [Indexed: 12/28/2022] Open
Abstract
Background The American Society of Colon and Rectal Surgeons is suggesting laparoscopic surgeries for colorectal cancer. Conventional perioperative procedures like long preoperative fasting and bowel procedures are not useful and harmful to patients undergoing surgeries for colorectal cancer. The objectives of the study were to compare surgery outcomes, hospital stays, and survival of patients who received fast-track (laparoscopy/open) surgical procedure followed by chemotherapy against those who received conventional (laparoscopy/open) surgical procedure followed by chemotherapy for colorectal cancer. Methods The study analyzes the outcomes of a total of 542 colorectal cancer (preoperative biopsies stage II or III) patients submitted to surgery and adjuvant chemotherapy. The study cohort is retrospectively subdivided in 4 groups submitted to open or laparoscopic resection with or without fast-track protocol appliance and two different chemotherapy regimens. Patients who ended up being TNM stage I have not received the adjuvant chemotherapy. Results The fast-track surgical procedure had shorter total hospital stays and postoperative hospital stays than the conventional surgical procedures. Flatus resumption time, the time until first defecation, and intraoperative blood loss were shorter for the fast-track surgical procedures than the conventional surgical procedures. Those surgery outcomes were also shorter for the fast-track laparoscopy than the open fast-track. Resumption of a fluid diet and ambulation onset time were shorter for the fast-track surgical procedures than the conventional surgical procedures. The surgical checkpoints that were compliance by patient of fast-track surgeries were significantly fewer than those of the conventional surgeries. Clinically significant difference for QLQ-C30/CR38 score after chemotherapy was reported between patients who received open conventional surgeries and those patients who received fast-track laparoscopy (59.63 ± 2.26 score/patient vs. 71.67 ± 5.19 score/patient). There were no significant differences for the number of patients with any grade adverse effects (p = 0.431) or with grade 3–4 adverse effects (p = 0.858), and the disease-free and overall survival among cohorts. Conclusions The fast-track surgical procedure is effective and safe even in a multidisciplinary scenario as colorectal cancer treatment in which surgery is only a part of management. Level of evidence: III Technical efficacy stage: 4.
Collapse
Affiliation(s)
- Baoxin Wang
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China
| | - Zhenming Wu
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China
| | - Rui Zhang
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China
| | - Yue Chen
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China
| | - Jiuxing Dong
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China
| | - Xiuheng Qi
- Department of Oncology, Hebei Petrochina Central Hospital, Heibei, Langfang, 065000, China.
| |
Collapse
|
2
|
Li J, Kong XX, Zhou JJ, Song YM, Huang XF, Li GH, Ying XJ, Dai XY, Lu M, Jiang K, Fu DL, Li XL, He JJ, Wang JW, Sun LF, Xu D, Xu JY, Chen M, Tian Y, Li JS, Yan M, Yuan Y, Ding KF. Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study. BMC Cancer 2019; 19:988. [PMID: 31647032 PMCID: PMC6806550 DOI: 10.1186/s12885-019-6188-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Accepted: 09/23/2019] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Laparoscopic surgery, fast-track perioperative treatment and XELOX chemotherapy are effective strategies for shortening the duration of hospital stay for cancer patients. This trial aimed to clarify the safety and efficacy of the fast-track multidisciplinary treatment (FTMDT) model compared to conventional surgery combined with chemotherapy in Chinese colorectal cancer patients. METHODS This trial was a prospective randomized controlled study with a 2 × 2 balanced factorial design and was conducted at six hospitals. Patients in group 1 (FTMDT) received fast-track perioperative treatment and XELOX adjuvant chemotherapy. Patients in group 2 (conventional treatment) received conventional perioperative treatment and mFOLFOX6 adjuvant chemotherapy. Subgroups 1a and 2a had laparoscopic surgery and subgroups 1b and 2b had open surgery. The primary endpoint was total length of hospital stay during treatment. RESULTS A total of 374 patients were randomly assigned to the four subgroups, and 342 patients were finally analyzed, including 87 patients in subgroup 1a, 85 in subgroup 1b, 86 in subgroup 2a, and 84 in subgroup 2b. The total hospital stay of group 1 was shorter than that of group 2 [13 days, (IQR, 11-17 days) vs. 23.5 days (IQR, 15-42 days), P = 0.0001]. Compared to group 2, group 1 had lower surgical costs, fewer in-hospital complications and faster recovery (all P < 0.05). Subgroup 1a showed faster surgical recovery than that of subgroup 1b (all P < 0.05). There was no difference in 5-year overall survival between groups 1 and 2 [87.1% (95% CI, 80.7-91.5%) vs. 87.1% (95% CI, 80.8-91.4%), P = 0.7420]. CONCLUSIONS The FTMDT model, which integrates laparoscopic surgery, fast-track treatment, and XELOX chemotherapy, was the superior model for enhancing the recovery of Chinese patients with colorectal cancer. TRIAL REGISTRATION ClinicalTrials.gov: NCT01080547 , registered on March 4, 2010.
Collapse
Affiliation(s)
- Jun Li
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Xiang-Xing Kong
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Jiao-Jiao Zhou
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Yong-Mao Song
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Xue-Feng Huang
- Department of Anus and Large Intestine, Sir Run Shaw Hospital, Zhejiang University College of Medicine, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China
| | - Gen-Hai Li
- Department of Anus and Large Intestine, People's Hospital of Yuyao, 800 City Road East, Yuyao, 315400, Zhejiang Province, China
| | - Xiao-Jiang Ying
- Department of Anorectum, People's Hospital of Shaoxing, 568 Zhong-Xing North Rd, Shaoxing, 312000, Zhejiang Province, China
| | - Xiao-Yu Dai
- Department of Anus and Large Intestine, Ningbo No. 2 Hospital, No. 41 Northwest Road, Ningbo, 315010, Zhejiang Province, China
| | - Min Lu
- Department of Anus and Large Intestine, Second Affiliated Hospital, Wenzhou Medicine College, 109 Xue-Yuan West Rd, Wenzhou, 325027, Zhejiang Province, China
| | - Kai Jiang
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Dong-Liang Fu
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Xin-Lin Li
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Jin-Jie He
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Jian-Wei Wang
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Li-Feng Sun
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Dong Xu
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
| | - Jing-Yan Xu
- Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China
| | - Min Chen
- Department of Anus and Large Intestine, Sir Run Shaw Hospital, Zhejiang University College of Medicine, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China
| | - Yu Tian
- Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou, 310027, Zhejiang, China
| | - Jing-Song Li
- Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou, 310027, Zhejiang, China
| | - Min Yan
- Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China
| | - Ying Yuan
- Department of Medical Oncology, Second Affiliated Hospital, and The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China
| | - Ke-Feng Ding
- Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
| |
Collapse
|
3
|
Xu D, Li J, Song Y, Zhou J, Sun F, Wang J, Duan Y, Hu Y, Liu Y, Wang X, Sun L, Wu L, Ding K. Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer. World J Surg Oncol 2015; 13:18. [PMID: 25649903 PMCID: PMC4337197 DOI: 10.1186/s12957-015-0445-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2014] [Accepted: 01/08/2015] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Many clinical trials had repeatedly shown that fast-track perioperative care and laparoscopic surgery are both preferred in the treatment of colorectal cancer. But few studies were designed to explore the diverse biochemical impacts of the two counterparts on human immunologic and nutritional status. METHODS Ninety-two cases of colorectal cancer patients meeting the inclusion criteria were randomized to four groups: laparoscopy with fast-track treatment (LAFT); open surgery with fast-track treatment (OSFT); laparoscopy with conventional treatment (LAC); open surgery with conventional treatment (OSC). Peripheral blood tests including nutritional factors (albumin, prealbumin, and transferrin), humoral immunologic factors (IgG, IgM, and IgA), and cellular immunologic factors (T and NK cells) were evaluated. Blood samples were collected preoperatively (baseline) and 12 and 96 h after surgery (indicated as POH12 and POH96, respectively). RESULTS Albumin, transferrin, prealbumin, and IgG levels were the highest in the LAFT group for both POH12 and POH96 time intervals. Repeated measures (two-way ANOVA) indicated that the difference of albumin, transferrin, and IgG level were attributed to surgery type (P < 0.05) and not perioperative treatment (P > 0.05). Only in the laparoscopy-included groups, the relative albumin and IgG levels of POH96 were obviously higher than that of POH12. CONCLUSION Laparoscopic surgery accelerated postoperative nutrition and immune levels rising again while fast-track treatment retarded the drop of postoperative nutrition and immune levels. Laparoscopic surgery might play a more important role than fast-track treatment in the earlier postoperative recovery of nutritional and immunologic status. Combined laparoscopic surgery with fast-track treatment provided best postoperative recovery of nutrition and immune status. These results should be further compared with the clinical outcomes of our FTMDT trial (clinicaltrials.gov: NCT01080547).
Collapse
Affiliation(s)
- Dong Xu
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Jun Li
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Yongmao Song
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Jiaojiao Zhou
- Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| | - Fangfang Sun
- Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| | - Jianwei Wang
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Yin Duan
- Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| | - Yeting Hu
- Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| | - Yue Liu
- Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| | - Xiaochen Wang
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Lifeng Sun
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Linshan Wu
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China.
| | - Kefeng Ding
- Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University, School of Medicine, Zhejiang, China. .,Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital, Zhejiang University, School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.
| |
Collapse
|
5
|
Agrafiotis AC, Corbeau M, Buggenhout A, Katsanos G, Ickx B, Van de Stadt J. Enhanced recovery after elective colorectal resection outside a strict fast-track protocol. A single centre experience. Int J Colorectal Dis 2014; 29:99-104. [PMID: 23982426 DOI: 10.1007/s00384-013-1767-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/20/2013] [Indexed: 02/04/2023]
Abstract
INTRODUCTION Optimising the management of hospitalised patients is a major concern. In colorectal surgery, the concept of enhanced recovery has been popularised by means of "fast-track" protocols, aiming at patient's discharge on the second postoperative day. Nevertheless, a strict fast-track protocol has several limitations. It is very demanding for the patient and therefore applicable only to a limited number of patients. AIM In order to optimise, in every aspect, the postoperative recovery of each patient undergoing an elective colorectal resection inside our institution, we set up a "soft" enhanced recovery programme. MATERIAL-METHODS A retrospective analysis was conducted in 92 patients evaluating the respective impact of protocol application throughout the duration of the hospital stay. RESULTS When all the required measures of our protocol were correctly implemented, the median discharge day was postoperative day 3 (range 3-5 days). On the contrary, when deviations occurred, they resulted in longer hospital stay (p < 0.001). Patients operated by laparoscopy were discharged earlier than patients operated by laparotomy (p < 0.001). The use of nasogastric tube and postoperative drainage prolonged significantly the length of stay (p = 0.001 and p < 0.001 respectively). When the urinary catheter was not removed or oral feeding not resumed on postoperative day 1, the patients were discharged later (p < 0.001). CONCLUSIONS There are substantial possibilities of optimising the recovery process after an elective colorectal resection, outside a strict fast-track protocol.
Collapse
Affiliation(s)
- A C Agrafiotis
- Clinic of Colorectal Surgery, Department of Digestive Surgery, Erasme University Hospital-Université Libre de Bruxelles, Brussels, Belgium,
| | | | | | | | | | | |
Collapse
|